BIOACTIVITY OF STREPTOMYCES AGAINST COLISTIN RESISTANT K. PNEUMONIAE ISOLATED FROM DIFFERENT CLINICAL SAMPLES

BIOACTIVITY OF STREPTOMYCES AGAINST COLISTIN RESISTANT K. PNEUMONIAE ISOLATED FROM DIFFERENT CLINICAL SAMPLES

This study was aimed to find a hopeful antibacterial product from Streptomyces spp. acts against colistin-resistant Klebsiella pneumoniae isolated from different clinical samples. Among 46 K. pneumoniae isolates, 4 (8.7%) isolates represented Colistin resistance using the disc diffusion method and...

Full description

Saved in:

Bibliographic Details
Main Authors:	Dalal S.AL-Rubaye, T. S. Al-Rubaye
Format:	Article
Language:	English
Published:	Baghdad University 2025-04-01
Series:	The Iraqi Journal of Agricultural science
Subjects:	soil; ESBLs; carbapenem; S. azureus; new, inhibitory
Online Access:	https://jcoagri.uobaghdad.edu.iq/index.php/intro/article/view/2191
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

In vitro emergence of carbapenem resistance in extended-spectrum β-lactamase-producing Klebsiella pneumoniae clinical isolates
by: Hugo E Villar, et al.
Published: (2015-02-01)

Investigation of Antibiotics Susceptibility and Resistance Pattern of ESBL and CRE Producing Escherichia coli and Klebsiella pneumonia Isolates from Northern Region of Saudi Arabia
by: Samreen Soomro, et al.
Published: (2024-12-01)

In vitro activity of ceftolozane/tazobactam against ESBL-producing enterobacterales in China: SMART 2016–2019
by: Wei Yu, et al.
Published: (2025-05-01)

Frequency and Antibiotics Resistance of Extended-Spectrum Beta-Lactamase (ESBLs) Producing Escherichia coli and Klebsiella pneumoniae Isolated from Patients in Gaza Strip, Palestine
by: Ghassan Tayh, et al.
Published: (2021-09-01)

Effect of colistin-tigecycline combination on colistin-resistant and carbapenem-resistant Klebsiella pneumoniae and Acinetobacter baumannii
by: Suyeon Park, et al.
Published: (2025-02-01)

IN VITRO ACTIVITY OF CEFTAZIDIME-AVIBACTAM AND COLISTIN AGAINST CARBAPENEM-RESISTANT PSEUDOMONAS AERUGINOSA CLINICAL ISOLATES
by: Tuğrul Hoşbul, et al.
Published: (2022-07-01)

Colistin broth disk elution for the detection of Colistin resistance among Carbapenem-resistant Klebsiella pneumoniae
by: Phu Thien Truong, et al.
Published: (2025-01-01)

Genomic dynamics of high-risk carbapenem-resistant Klebsiella pneumoniae clones carrying hypervirulence determinants in Egyptian clinical settings
by: Nehal Adel Abdelsalam, et al.
Published: (2024-10-01)

Management practices and mortality predictors among Klebsiella pneumoniae infections across Lebanese hospitals: a multicenter retrospective study
by: Rania Itani, et al.
Published: (2025-04-01)

ESBL-Producing <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> Exhibit Divergent Paths During In-Human Evolution Towards Carbapenem Resistance
by: Michelle Chioma Kalu, et al.
Published: (2025-06-01)

Colistin-resistant Klebsiella pneumoniae species complex: The scenario in Mexico
by: Jonathan Rodríguez-Santiago, et al.
Published: (2025-06-01)

Assessment of in vitro activity of ceftazidime/avibactam on carbapenemase‐producing Enterobacterales from Iran: An experimental study
by: Mehri Haeili, et al.
Published: (2024-08-01)

The causes and outcomes of nosocomial meningitis by pathogens for which new antibiotics are urgently needed
by: Yi Ye, et al.
Published: (2025-04-01)

Treatment of infections caused by critically resistant Klebsiella pneumoniae strains: Current challenges and future prospectives.
by: Amira M. El-Ganiny
Published: (2024-12-01)

Predicting the Effect of Meropenem Against <i>Klebsiella pneumoniae</i> Using Minimum Inhibitory Concentrations Determined at High Inocula
by: Maria V. Golikova, et al.
Published: (2025-03-01)

Successful Control of a Colistin and Carbapenem Resistant Klebsiella pneumoniae Outbreak in an Intensive Care Unit
by: Ahsen Öncül, et al.
Published: (2025-04-01)

Mortality and clinical outcomes of colistin versus colistin-based combination therapy for infections caused by Multidrug-resistant Acinetobacter baumannii in critically ill patients
by: Marwan J. Alwazzeh, et al.
Published: (2025-03-01)

Determination of Colistin Resistance in Clinical Isolates from Healthcare Facilities in Mthatha and Surrounding Areas
by: Silindokuhle Ndlela, et al.
Published: (2025-05-01)

Mutant prevention concentrations of ciprofloxacin against urinary isolates of Escherichia coli and Klebsiella pneumoniae
by: Ziad Daoud, et al.
Published: (2014-02-01)

Characteristics of ESBL-positive Klebsiella pneumoniae isolated from paired children with and without diarrhea
by: Yuan Zhang, et al.
Published: (2025-05-01)

The ability of K. pneumoniae isolated from nosocomial infections to the synthesis of β-lactamase
by: S. A. Atakishizadeh
Published: (2019-04-01)

Investigation of carbapenemase and mcr-1 genes in carbapenem-resistant Klebsiella pneumoniae isolates
by: Çiğdem Arabacı, et al.
Published: (2019-06-01)

Molecular epidemiology and clinical characteristics of carbapenem-resistant Klebsiella pneumoniae bloodstream and pneumonia isolates
by: Phillip B. Cox, et al.
Published: (2025-08-01)

Molecular characterization of Extended Spectrum Beta lactamases producing bacteria causing Chronic Suppurative Otitis Media in South India
by: A.V. Kavitha1, et al.
Published: (2021-12-01)

Detection of multidrug resistant Klebsiella pneumoniae isolated from duck cloacal swab in Jombang, Indonesia
by: Naomi Lan Noviana Thesia, et al.
Published: (2025-01-01)

Diverse genetic characteristics of ESBL-producing Klebsiella pneumoniae isolates from obstetrics & gynaecology settings in some major hospitals, China
by: Xiao-Mei Zhang, et al.
Published: (2021-06-01)

Detection of 16S rRNA Methylases and Co-Resistance with β-lactams among Klebsiella pneumoniae Isolates from Iraqi Patients
by: Mustafa et al.
Published: (2019-09-01)

Carbapenem and colistin resistance in children with Enterobacteriaceae infections
by: Zeliha Haytoğlu, et al.
Published: (2020-10-01)

An Assessment Of Cefiderocol's Synergistic Effects With Eravacycline, Colistin, Meropenem, Levofloxacin, Ceftazidime/Avibactam, And Tobramycin Against Carbapenem-Resistant Pseudomonas Aeruginosa
by: Bekir Özer, et al.
Published: (2024-12-01)

Potential effectiveness of Morchella conica and Morchella esculenta extracts against carbapenem resistant Acinetobacter baumannii
Published: (2025-04-01)

Clinical and microbiological analyses of colistin-resistant strains among carbapenem-resistant Enterobacter cloacae complex clinical isolates
by: Jinyoung Yang, et al.
Published: (2025-02-01)

Ceftazidime-avibactam susceptibility against Escherichia coli and Klebsiella pneumoniae
by: Arun Sachu, et al.
Published: (2025-02-01)

Real-world data on the effects of colistin sulfate and polymyxin B sulfate in the treatment of pneumonia induced by CR-GNB
by: Di Liu, et al.
Published: (2024-07-01)

Evaluation of Co-production of Colistin Resistance and ESBL Genes among Gram-negative Clinical Isolates from Usmanu Danfodiyo University Teaching Hospital Sokoto, Nigeria
by: Tanko Nuhu, et al.
Published: (2024-06-01)

Molecular Profile of Emerging Hypervirulent Klebsiella pneumoniae Clinical Isolates in Diabetic Patients
by: A. Karthik, et al.
Published: (2025-03-01)

Epidemiology and Resistance Profiles of Bacteria Isolated From Blood Samples in Septic Patients at Emergency Department Admission: A 6-Year Single Centre Retrospective Analysis From Northern Italy
by: Valeria Cento, et al.
Published: (2025-03-01)

Molecular epidemiological investigation of carbapenem resistant Klebsiella pneumoniae isolated from intensive care unit patients of six geographical regions of Turkey
by: Şükran Köse, et al.
Published: (2023-10-01)

Cefmetazole, flomoxef, and meropenem are effective against planktonic cells but not biofilms of extended-spectrum β-lactamase-producing Escherichia coli
by: Nami Hatayama, et al.
Published: (2025-07-01)

Phenotypic and genotypic characterization of Beta-lactamases in clinical isolates of Escherichia coli and Klebsiella pneumoniae from patients in Kinshasa, Democratic Republic of Congo
by: Cyprien MBUNDU LUKUKULA, et al.
Published: (2025-08-01)

Are New β-Lactam/β-Lactamase Inhibitor Combinations Promising Against Carbapenem-Resistant <i>K. pneumoniae</i> Isolates?
by: Ayşe Nur Ceylan, et al.
Published: (2025-02-01)